Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.65, No.3, p.436-440, 2018 |
||
Title: Hashimoto’s thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients | ||
Author: H. MA, L. LI, K. LI, T. WANG, Y. ZHANG, C. ZHANG, Y. XU, X. WU, J. YU, H. WANG, B. XIANG, W. WANG, R. ZHANG | ||
Abstract: Papillary thyroid carcinoma (PTC) is often combined with other types of thyroid disease, such as Hashimoto’s thyroiditis (HT), nodular goiter (NG), follicular adenoma (FA) and other types. However, the function of these diseases in PTC tumori- genesis and development is not well understood. In this research, 563 PTC patients were recruited and divided into two groups according to pathological diagnosis, namely simple PTC (PTC) and PTC combined with other thyroid diseases (PTC+). Clinicopathological characteristics and BRAFV600E mutation status were compared between PTC and PTC+. Our data showed that there was a statistically significant difference in gender (p=0.007), tumor diameter (5 mm, p=0.012; 1 cm, p=0.042), lymph node metastasis (p=0.000) and BRAFV600E mutation status (p=0.001) between PTC and PTC+. PTC+ patients have lower lymph node metastasis rate, even if PTC nodule diameter is larger than 5 mm (p=0.005) or ≥1 cm (p=0.049) or BRAFV600E is mutated (p=0.001). In conclusion, our study suggests that HT, NG and FA, are protective factors of PTC patients, and PTC+ patients have lower lymph node metastasis and BRAFV600E mutation rate compared with simple PTC patients. |
||
Keywords: papillary thyroid carcinoma, combined papillary thyroid carcinoma, protective effect, BRAF | ||
Published online: 16-May-2018 | ||
Year: 2018, Volume: 65, Issue: 3 | Page From: 436, Page To: 440 | |
doi:10.4149/neo_2018_170428N317 |
||
|
download file |
|